Stem Cell Mutations Explored

Luntz, Stephen
March 2012
Australasian Science;Mar2012, Vol. 33 Issue 2, p5
The article discusses a research study on pluripotent stem cells which found that there are higher mutation rates in the induced pluripotent stem cell (iPS) lines as compared with the human embryonic stem (HES) cell lines.


Related Articles

  • Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome. Bellin, Milena; Casini, Simona; Davis, Richard P; D'Aniello, Cristina; Haas, Jessica; Ward-van Oostwaard, Dorien; Tertoolen, Leon G J; Jung, Christian B; Elliott, David A; Welling, Andrea; Laugwitz, Karl-Ludwig; Moretti, Alessandra; Mummery, Christine L // EMBO Journal;12/11/2013, Vol. 32 Issue 24, p3161 

    Patient-specific induced pluripotent stem cells (iPSCs) will assist research on genetic cardiac maladies if the disease phenotype is recapitulated in vitro. However, genetic background variations may confound disease traits, especially for disorders with incomplete penetrance, such as long-QT...

  • Session 53: Are human embryonic stem cells ready for regenerative medicine?  // Human Reproduction;Jun2013, Vol. 28 Issue suppl_1, pi84 

    No abstract available.

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

  • Putting induced pluripotent stem cells to the test. Vallier, Ludovic // Nature Biotechnology;Nov2015, Vol. 33 Issue 11, p1145 

    The article focuses on the sustainability of Human induced pluripotent stem cells (hiPSCs) for supporting clinical applications. Topics discussed include new possibilities for personalized cell therapy after the discovery that human somatic cell can be reprogrammed into a pluripotent stem cell,...

  • An in vivo model of human small intestine using pluripotent stem cells. Watson, Carey L; Helmrath, Michael A; Mahe, Maxime M; Sundaram, Nambirajan; Poling, Holly M; Múnera, Jorge; Schweitzer, Jamie I; Mayhew, Christopher N; Wells, James M; Howell, Jonathan C; Vallance, Jefferson E; Sun, Ying; Grabowski, Gregory; Finkbeiner, Stacy R; Spence, Jason R; Shroyer, Noah F // Nature Medicine;Nov2014, Vol. 20 Issue 11, p1310 

    Differentiation of human pluripotent stem cells (hPSCs) into organ-specific subtypes offers an exciting avenue for the study of embryonic development and disease processes, for pharmacologic studies and as a potential resource for therapeutic transplant. To date, limited in vivo models exist for...

  • Antibody-Directed Lentiviral Gene Transduction for Live-Cell Monitoring and Selection of Human iPS and hES Cells. Dai-tze Wu; Seita, Yasunari; Xia Zhang; Chi-Wei Lu; Roth, Monica J. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    The identification of stem cells within a mixed population of cells is a major hurdle for stem cell biology-in particular, in the identification of induced pluripotent stem (iPS) cells during the reprogramming process. Based on the selective expression of stem cell surface markers, a method to...

  • Strategies for enrichment and selection of stem cell-derived tissue precursors. Bernstein, Harold S.; Hyun, William C. // Stem Cell Research & Therapy;2012, Vol. 3 Issue 3, p1 

    Human embryonic stem cells have the capacity for self-renewal and pluripotency and thus are a primary candidate for tissue engineering and regenerative therapies. These cells also provide an opportunity to study the development of human tissues ex vivo. To date, numerous human embryonic stem...

  • Human pluripotent stem cell-derived cardiomyocytes for heart regeneration, drug discovery and disease modeling: from the genetic, epigenetic, and tissue modeling perspectives. Chow, Maggie Zi; Boheler, Kenneth R.; Li, Ronald A. // Stem Cell Research & Therapy;2013, Vol. 4 Issue 4, p1 

    Heart diseases remain a major cause of mortality and morbidity worldwide. However, terminally differentiated human adult cardiomyocytes (CMs) possess a very limited innate ability to regenerate. Directed differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells...

  • European stem cell research in legal shackles. Nielen, Myrthe G; de Vries, Sybe A; Geijsen, Niels // EMBO Journal;12/11/2013, Vol. 32 Issue 24, p3107 

    Advances in stem cell biology have raised legal challenges to the patentability of stem cells and any derived technologies and processes. In 1999, Oliver Brüstle was granted a patent for the generation and therapeutic use of neural cells derived from human embryonic stem cells (hESCs). The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics